Glioblastoma brain cancer research: Study provides glimmer of hope

A new study by Mass General Brigham researchers provides a glimmer of hope for patients with glioblastoma, the most common and deadly form of brain cancer in adults.
The researchers found that glioblastoma patients who received a common anti-seizure and pain drug — gabapentin — ended up living longer.
“This study is an exciting step forward,” said lead author Joshua Bernstock, a clinical fellow in the Department of Neurosurgery at Brigham and Women’s Hospital.
&ldqu